Song, J., Morgan, A. A., Ahn, J., Li, W. F., Chang, Y., Chang, Y.-C., Fahimuddin, M., Chi, K.-Y., Wu, L. W., & Chiang, C.-H. (2025). Validating Khorana Risk Score in gastric cancer patients on immune checkpoint inhibitors and chemotherapy. Immunotherapy, 17(6), 419–424. https://doi.org/10.1080/1750743x.2025.2501922

Kinoshita, H., Lian, G., & Hayakawa, Y. (2025). Gastric Cancer Origins: Stem Cells, Metaplasia, and Environmental Interactions. Cancer Prevention Research, 18(5), 257–259. https://doi.org/10.1158/1940-6207.capr-25-0072

Abate, M., Stroobant, E. E., Fei, T., Lin, Y.-H., Shimada, S., Drebin, H., Chen, E., Tang, L. H., Shah, S. P., Wolchok, J. D., Janjigian, Y. Y., Strong, V. E., & Vardhana, S. A. (2025). Host Tissue Factors Predict Immune Surveillance and Therapeutic Outcomes in Gastric Cancer. Cancer Immunology Research, 13(4), 591–601. https://doi.org/10.1158/2326-6066.cir-23-0563

Andersen, G. T., Ianevski, A., Resell, M., Pojskic, N., Rabben, H.-L., Geithus, S., Kodama, Y., Hiroyuki, T., Kainov, D., Grønbech, J. E., Hayakawa, Y., Wang, T. C., Zhao, C.-M., & Chen, D. (2024). Multi-bioinformatics revealed potential biomarkers and repurposed drugs for gastric adenocarcinoma-related gastric intestinal metaplasia. Npj Systems Biology and Applications, 10(1). https://doi.org/10.1038/s41540-024-00455-0

Wu, L. W., Jang, S. J., Shapiro, C., Fazlollahi, L., Wang, T. C., Ryeom, S. W., & Moy, R. H. (2024). Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics. Targeted Oncology, 19(6), 845–865. https://doi.org/10.1007/s11523-024-01097-2

Matsubayashi, C. O., Cheng, S., Hulchafo, I., Zhang, Y., Tada, T., Buxbaum, J. L., & Ochiai, K. (2024). Artificial intelligence for gastric cancer in endoscopy: From diagnostic reasoning to market. Digestive and Liver Disease, 56(7), 1156–1163. https://doi.org/10.1016/j.dld.2024.04.019

Henick, B. S., & Moy, R. H. (2024). TAPping Into PD-L1 Testing Efficiency for Gastroesophageal Cancer. JCO Precision Oncology, 8. https://doi.org/10.1200/po.24.00344

Rustgi, N., Wu, S., Samec, T., Walker, P., Xiu, J., Lou, E., Goel, S., Saeed, A., & Moy, R. H. (2024). Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer. Cancer Research Communications, 4(6), 1399–1409. https://doi.org/10.1158/2767-9764.crc-23-0496

Zhang, F., Sahu, V., Peng, K., Wang, Y., Li, T., Bala, P., Aitymbayev, D., Sahgal, P., Schaefer, A., Der, C. J., Ryeom, S., Yoon, S., Sethi, N., Bass, A. J., & Zhang, H. (2024). Recurrent RhoGAP gene fusion CLDN18-ARHGAP26 promotes RHOA activation and focal adhesion kinase and YAP-TEAD signalling in diffuse gastric cancer. Gut, 73(8), 1280–1291. https://doi.org/10.1136/gutjnl-2023-329686

Arai, J., Hayakawa, Y., Tateno, H., Murakami, K., Hayashi, T., Hata, M., Matsushita, Y., Kinoshita, H., Abe, S., Kurokawa, K., Oya, Y., Tsuboi, M., Ihara, S., Niikura, R., Suzuki, N., Iwata, Y., Shiokawa, T., Shiomi, C., Uekura, C., … Fujishiro, M. (2024). Impaired Glycosylation of Gastric Mucins Drives Gastric Tumorigenesis and Serves as a Novel Therapeutic Target. Gastroenterology, 167(3), 505-521.e19. https://doi.org/10.1053/j.gastro.2024.03.037

Mülder, D. T., Hahn, A. I., Huang, R. J., Zhou, M. J., Blake, B., Omofuma, O., Murphy, J. D., Gutiérrez-Torres, D. S., Zauber, A. G., O’Mahony, J. F., Camargo, M. C., Ladabaum, U., Yeh, J. M., Hur, C., Lansdorp-Vogelaar, I., Meester, R., & Laszkowska, M. (2024). Prevalence of Gastric Precursor Lesions in Countries With Differential Gastric Cancer Burden: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology, 22(8), 1605-1617.e46. https://doi.org/10.1016/j.cgh.2024.02.023

Wu, S. P., Keshavjee, S. H., Yoon, S. S., & Kwon, S. (2023). Survival Outcomes and Patterns of Care for Stage II or III Resected Gastric Cancer by Race and Ethnicity. JAMA Network Open, 6(12), e2349026. https://doi.org/10.1001/jamanetworkopen.2023.49026

Schaefer, A., Hodge, R. G., Zhang, H., Hobbs, G. A., Dilly, J., Huynh, M. V., Goodwin, C. M., Zhang, F., Diehl, J. N., Pierobon, M., Baldelli, E., Javaid, S., Guthrie, K., Rashid, N. U., Petricoin, E. F., Cox, A. D., Hahn, W. C., Aguirre, A. J., Bass, A. J., & Der, C. J. (2023). RHOAL57Vdrives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling. Science Signaling, 16(816). https://doi.org/10.1126/scisignal.adg5289

Rustgi, S. D., McKinley, M., McBay, B., Zylberberg, H. M., Gomez, S. L., Hur, C., Kastrinos, F., Gupta, S., Kim, M. K., Itzkowitz, S. H., & Shah, S. C. (2023). Epidemiology of Gastric Malignancies 2000–2018 According to Histology: A Population-Based Analysis of Incidence and Temporal Trends. Clinical Gastroenterology and Hepatology, 21(13), 3285-3295.e8. https://doi.org/10.1016/j.cgh.2023.01.037

Manji, G. A., Lee, S., Del Portillo, A., May, M., Ana, S. S., Alouani, E., Sender, N., Negri, T., Gautier, K., Ge, L., Fan, W., Xie, M., Sethi, A., Schrope, B., Tan, A. C., Park, H., Oberstein, P. E., Shah, M. A., & Raufi, A. G. (2023). Chemotherapy and Immune Checkpoint Blockade for Gastric and Gastroesophageal Junction Adenocarcinoma. JAMA Oncology, 9(12), 1702. https://doi.org/10.1001/jamaoncol.2023.4423

Laszkowska, M., Zhang, X., Kuliszewski, M. G., Hur, C., Lim, F., Rogers, A., & Xinhui Tan, S. (2023). Heightened Risk for Gastric Cancer Among Immigrant Populations in New York State From High-Incidence Countries. Clinical Gastroenterology and Hepatology, 21(10), 2673-2675.e3. https://doi.org/10.1016/j.cgh.2022.08.008

Cytryn, S. L., Moy, R. H., Cowzer, D., Shah, R. H., Chou, J. F., Joshi, S. S., Ku, G. Y., Maron, S. B., Desai, A., Yang, J., Sugarman, R., Rao, D., Goldberg, Z., Charalambous, C., Lapshina, M., Antoine, A., Socolow, F., Trivedi, N., Capanu, M., … Janjigian, Y. Y. (2023). First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial. The Lancet Oncology, 24(10), 1073–1082. https://doi.org/10.1016/s1470-2045(23)00358-3

Schreidah, C. M., Fahmy, L. M., Lapolla, B. A., Kwinta, B. D., Magro, C. M., & Geskin, L. J. (2023). Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn’s Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab. The American Journal of Dermatopathology, 45(8), 572–576. https://doi.org/10.1097/dad.0000000000002470

Rustgi, S. D., Zylberberg, H. M., Hur, C., & Shah, S. C. (2023). Management of Gastric Intestinal Metaplasia. Clinical Gastroenterology and Hepatology, 21(9), 2178–2182. https://doi.org/10.1016/j.cgh.2023.03.010

Yoon, C., Lu, J., Jun, Y., Suh, Y.-S., Kim, B.-J., Till, J. E., Kim, J. H., Keshavjee, S. H., Ryeom, S., & Yoon, S. S. (2023). RETRACTED ARTICLE: KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis. BMC Cancer, 23(1). https://doi.org/10.1186/s12885-023-11170-0

Abel, M. K., Myers, E. L., Minkin, E., Tahir, P., Haynes, A. B., Wright, J. D., Rauh‐Hain, J. A., & Melamed, A. (2023). Cancer‐directed surgery in patients with metastatic cancer: A systematic review and meta‐analysis of randomized evidence. Cancer Medicine, 12(13), 14072–14083. Portico. https://doi.org/10.1002/cam4.6061

Ma, L., Liu, Y., Wang, Y., Yang, J., Lu, J., Feng, H., Ye, S., & Liu, Y. (2023). Identification of PTPN20 as an innate immunity-related gene in gastric cancer with Helicobacter pylori infection. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1212692

Ko, A. H., Kim, K.-P., Siveke, J. T., Lopez, C. D., Lacy, J., O’Reilly, E. M., Macarulla, T., Manji, G. A., Lee, J., Ajani, J., Alsina Maqueda, M., Rha, S.-Y., Lau, J., Al-Sakaff, N., Allen, S., Lu, D., Shemesh, C. S., Gan, X., Cha, E., & Oh, D.-Y. (2023). Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform. The Oncologist, 28(6), 553-e472. https://doi.org/10.1093/oncolo/oyad022

Chen, Q., Weng, K., Lin, M., Jiang, M., Fang, Y., Chung, S. S. W., Huang, X., Zhong, Q., Liu, Z., Huang, Z., Lin, J., Li, P., El-Rifai, W., Zaika, A., Li, H., Rustgi, A. K., Nakagawa, H., Abrams, J. A., Wang, T. C., … Que, J. (2023). SOX9 Modulates the Transformation of Gastric Stem Cells Through Biased Symmetric Cell Division. Gastroenterology, 164(7), 1119-1136.e12. https://doi.org/10.1053/j.gastro.2023.01.037

Quante, M., Wang, T. C., & Bass, A. J. (2022). Adenocarcinoma of the oesophagus: is it gastric cancer? Gut, 72(6), 1027–1029. https://doi.org/10.1136/gutjnl-2022-327096

Yoon, C., Lu, J., Kim, B.-J., Cho, S.-J., Kim, J. H., Moy, R. H., Ryeom, S. W., & Yoon, S. S. (2023). Patient-Derived Organoids from Locally Advanced Gastric Adenocarcinomas Can Predict Resistance to Neoadjuvant Chemotherapy. Journal of Gastrointestinal Surgery, 27(4), 666–676. https://doi.org/10.1007/s11605-022-05568-7

Minikes, A. M., Song, Y., Feng, Y., Yoon, C., Yoon, S. S., & Jiang, X. (2023). E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer. Oncogene, 42(11), 848–857. https://doi.org/10.1038/s41388-023-02599-5

Peng, K., Zhang, F., Wang, Y., Sahgal, P., Li, T., Zhou, J., Liang, X., Zhang, Y., Sethi, N., Liu, T., Zhang, H., & Bass, A. J. (2022). Development of Combination Strategies for Focal Adhesion Kinase Inhibition in Diffuse Gastric Cancer. Clinical Cancer Research, 29(1), 197–208. https://doi.org/10.1158/1078-0432.ccr-22-1609

Venkat, M., & Visrodia, K. (2023). Management of Adverse Events of Submucosal Endoscopy. Gastrointestinal Endoscopy Clinics of North America, 33(1), 183–196. https://doi.org/10.1016/j.giec.2022.09.005

Stillman, M. D., Kusche, N., Toledano, S., Hilfrank, K. J., Yoon, C., Gabre, J. T., Rustgi, S. D., Hur, C., Kastrinos, F., Ryeom, S. W., & Yoon, S. S. (2022). Short and long‐term outcomes of prophylactic total gastrectomy in 54 consecutive individuals with germline pathogenic mutations in the CDH1 gene. Journal of Surgical Oncology, 126(8), 1413–1422. Portico. https://doi.org/10.1002/jso.27084

Sharzehi, K., Sethi, A., & Savides, T. (2022). AGA Clinical Practice Update on Management of Subepithelial Lesions Encountered During Routine Endoscopy: Expert Review. Clinical Gastroenterology and Hepatology, 20(11), 2435-2443.e4. https://doi.org/10.1016/j.cgh.2022.05.054

Laszkowska, M., Truong, H., Faye, A. S., Kim, J., Tan, S. X., Lim, F., Abrams, J. A., & Hur, C. (2021). Prevalence of Extensive and Limited Gastric Intestinal Metaplasia and Progression to Dysplasia and Gastric Cancer. Digestive Diseases and Sciences, 67(8), 3693–3701. https://doi.org/10.1007/s10620-021-07276-9

Kang, S., Park, M., Cho, J. Y., Ahn, S. jin, Yoon, C., Kim, S. G., & Cho, S.-J. (2022). Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma. Gastric Cancer, 25(4), 678–696. https://doi.org/10.1007/s10120-022-01290-0

Palrasu, M., Zaika, E., Paulrasu, K., Caspa Gokulan, R., Suarez, G., Que, J., El-Rifai, W., Peek, R. M., Garcia-Buitrago, M., & Zaika, A. I. (2022). Helicobacter pylori pathogen inhibits cellular responses to oncogenic stress and apoptosis. PLOS Pathogens, 18(6), e1010628. https://doi.org/10.1371/journal.ppat.1010628

Stillman, M. D., & Yoon, S. S. (2022). Open and minimally invasive gastrectomy in Eastern and Western patient populations: A review of the literature and reasons for differences in outcomes. Journal of Surgical Oncology, 126(2), 279–291. Portico. https://doi.org/10.1002/jso.26887

Zheng, B., Artin, M. G., Chung, H., Chen, B., Sun, S., May, B. L., Hur, C., Green, P. H. R., Wang, T. C., Park, J., & Kong, X. (2022). Immunogenetics of gastrointestinal cancers: A systematic review and retrospective survey of inborn errors of immunity in humans. Journal of Gastroenterology and Hepatology, 37(6), 973–982. Portico. https://doi.org/10.1111/jgh.15848

Ekheden, I., Ludvigsson, J. F., Yin, L., Elbe, P., & Ye, W. (2022). Esophageal abnormalities and the risk for gastroesophageal cancers—a histopathology-register-based study in Sweden. European Journal of Epidemiology, 37(4), 401–411. https://doi.org/10.1007/s10654-021-00833-6

Moy, R. H., Walch, H. S., Mattar, M., Chatila, W. K., Molena, D., Strong, V. E., Tang, L. H., Maron, S. B., Coit, D. G., Jones, D. R., Hechtman, J. F., Solit, D. B., Schultz, N., de Stanchina, E., & Janjigian, Y. Y. (2022). Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts. JCO Precision Oncology, 6. https://doi.org/10.1200/po.21.00242

Moy, R. H., Greally, M., Chou, J. F., Li, J., Desai, A. M., Chalasani, S. B., Won, E., Kelsen, D. P., Ilson, D. H., Janjigian, Y. Y., Capanu, M., & Ku, G. Y. (2022). Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma. Cancer Chemotherapy and Pharmacology, 89(2), 255–265. https://doi.org/10.1007/s00280-021-04384-1

Hu, Y., & Yoon, S. S. (2022). Extent of gastrectomy and lymphadenectomy for gastric adenocarcinoma. Surgical Oncology, 40, 101689. https://doi.org/10.1016/j.suronc.2021.101689

Pumpalova, Y. S., Segall, L., Felli, R., Bhatkhande, G., Jacobson, J. S., & Neugut, A. I. (2021). The Impact of HIV on Non-AIDS defining gastrointestinal malignancies: A review. Seminars in Oncology, 48(3), 226–235. https://doi.org/10.1053/j.seminoncol.2021.09.001

Schrope, B., Coons, B., Rosario, V., & Toledano, S. (2021). Proximal Gastrectomy Is a Viable Alternative to Total Gastrectomy in Early Stage Proximal Gastric Cancer. JSLS : Journal of the Society of Laparoscopic & Robotic Surgeons, 25(3), e2021.00017. https://doi.org/10.4293/jsls.2021.00017